22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

ACTIVATE: A pilot randomized Activity Coaching Trial to Increase Vitality and Energy during post-operative pelvic radiation therapy for endometrial cancer

23 Jul 2026, 11:45
1h 15m
Heidelberg Congress Center ( Heidelberg Congress Center )

Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Poster Session

Speaker

Dr Melissa Miller (Inova Peterson Life with Cancer)

Description

Background: Women with endometrial cancer experience substantial symptom burden during adjuvant pelvic radiation therapy (PRT), with cancer-related fatigue among the most debilitating. Fatigue is exacerbated by recent surgery, older age, obesity, and treatment-related side effects, making exercise challenging. This trial evaluates the feasibility and preliminary efficacy of personalized exercise coaching delivered during post-surgical PRT versus initiating exercise 5-7 weeks post PRT, enabling assessment during treatment and early recovery.
Methods: Sixteen women with Stage I–IVA endometrial cancer scheduled to receive adjuvant PRT after total/modified radical hysterectomy are randomized to immediate or delayed coaching using an attention-control design. The intervention is a 10-week personalized exercise-coaching program with weekly sessions helping participants achieve ≥150 minutes/week of moderate activity. The immediate group begins coaching at PRT initiation; the delayed group 5-7 weeks post-PRT. Participants wear an activity monitor and complete patient-reported outcomes at baseline, post-PRT, 5-7w post-PRT, and 6-mo follow-up: fatigue (FACIT-Fatigue), bowel/urinary toxicity (EPIC), sexual function (PROMIS), and quality of life (PROMIS-29+2). Functional capacity is assessed via six-minute walk test (6MWT). Feasibility benchmarks: ≥50% provider acceptability; ≥50% patient acceptability; ≥50% appropriateness of screening criteria; ≥70% adherence to coaching and device wear. Enrollment began January 2025 and is expected to conclude January 2026, with follow-up completed by July 2026.
Preliminary Results: Thirteen participants have enrolled to date (54% non-Hispanic White, 15% non-Hispanic Black, 15% Hispanic, 8% Middle Eastern/North African). Baseline mean weight was 79.4 kg, height 63.6 inches, 6MWT distance 1168 meters. Six women were randomized to immediate start and 7 to delayed. Assessment completion is 100% at baseline, post-PRT, 6mo follow-up; 86% at 5-7w post-PRT. Three participants withdrew for unrelated reasons (PRT side-effects, medical issue, social hardship). Five have completed the study, all meeting feasibility benchmarks.
Conclusions: Early findings indicate good feasibility and acceptability, supporting the feasibility of delivering exercise coaching during PRT.

Keywords

Endometrial cancer; Pelvic radiation therapy; Pilot randomized trial; Exercise coaching; Cancer-related fatigue

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Authors

Dr Avani Rao (Radiation Oncology Associates of the National Capital Region, Inova Schar Cancer) Ms Kirstie Pomaranski (Inova Peterson Life with Cancer) Mr Rahul Bashyal (Inova Peterson Life with Cancer) Ms Kayla Hartso (Inova Schar Cancer) Ms Karen Lopez-Jovel (Inova Peterson Life with Cancer) Ms Tuyetson Nguyen (Inova Peterson Life with Cancer) Ms Jeanne Pasha (Inova Peterson Life with Cancer) Ms Natasha Raja (Inova Schar Cancer) Ms Natasha Toussaint (Inova Schar Cancer) Dr Melissa Miller (Inova Peterson Life with Cancer)

Presentation materials

There are no materials yet.